James Hartley 2026. Aberrant Splicing Factor SF3A2 as a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay with Immune Infiltration and Natural Product Intervention. International Journal of Medical Science and Dental Health. 12, 09 (Sep. 2026), 176–181. DOI:https://doi.org/10.55640/ijmsdh-12-09-20.